Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Irbesartan Market Growth 2022-2028

  • LP 4832850
  • 127 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Irbesartan will have significant change from previous year. According to our (LP Information) latest study, the global Irbesartan market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Irbesartan market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Irbesartan market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Irbesartan market, reaching US$ million by the year 2028. As for the Europe Irbesartan landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Irbesartan players cover Teva, Sanofi, BMS, and Sumitomo Dainippon Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Irbesartan market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Combination Drugs

Prescribed Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hyperlipidemia

High Blood Pressure

Heart Failure

Kidney Disease

Fibrous Fibrillation

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Teva

Sanofi

BMS

Sumitomo Dainippon Pharma

Novartis

Shionogi

Hanall

Taj Pharmaceuticals

Apotex

Jiangsu Hengrui Medicine

Verdant Life Sciences

Angita Pharma

Auro Pharma

Avanstra

Zhuhai Rundu Pharma

Xiansheng Pharmaceutical

CTTQ

Tianjin Huairen Pharmaceutical

Jiangsu Wangao Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhejiang Ainuo Pharmaceutical

Yuanhe Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Irbesartan Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Irbesartan by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Irbesartan by Country/Region, 2017, 2022 & 2028

2.2 Irbesartan Segment by Type

2.2.1 Combination Drugs

2.2.2 Prescribed Drugs

2.3 Irbesartan Sales by Type

2.3.1 Global Irbesartan Sales Market Share by Type (2017-2022)

2.3.2 Global Irbesartan Revenue and Market Share by Type (2017-2022)

2.3.3 Global Irbesartan Sale Price by Type (2017-2022)

2.4 Irbesartan Segment by Application

2.4.1 Hyperlipidemia

2.4.2 High Blood Pressure

2.4.3 Heart Failure

2.4.4 Kidney Disease

2.4.5 Fibrous Fibrillation

2.4.6 Other

2.5 Irbesartan Sales by Application

2.5.1 Global Irbesartan Sale Market Share by Application (2017-2022)

2.5.2 Global Irbesartan Revenue and Market Share by Application (2017-2022)

2.5.3 Global Irbesartan Sale Price by Application (2017-2022)

3 Global Irbesartan by Company

3.1 Global Irbesartan Breakdown Data by Company

3.1.1 Global Irbesartan Annual Sales by Company (2020-2022)

3.1.2 Global Irbesartan Sales Market Share by Company (2020-2022)

3.2 Global Irbesartan Annual Revenue by Company (2020-2022)

3.2.1 Global Irbesartan Revenue by Company (2020-2022)

3.2.2 Global Irbesartan Revenue Market Share by Company (2020-2022)

3.3 Global Irbesartan Sale Price by Company

3.4 Key Manufacturers Irbesartan Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Irbesartan Product Location Distribution

3.4.2 Players Irbesartan Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Irbesartan by Geographic Region

4.1 World Historic Irbesartan Market Size by Geographic Region (2017-2022)

4.1.1 Global Irbesartan Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Irbesartan Annual Revenue by Geographic Region

4.2 World Historic Irbesartan Market Size by Country/Region (2017-2022)

4.2.1 Global Irbesartan Annual Sales by Country/Region (2017-2022)

4.2.2 Global Irbesartan Annual Revenue by Country/Region

4.3 Americas Irbesartan Sales Growth

4.4 APAC Irbesartan Sales Growth

4.5 Europe Irbesartan Sales Growth

4.6 Middle East & Africa Irbesartan Sales Growth

5 Americas

5.1 Americas Irbesartan Sales by Country

5.1.1 Americas Irbesartan Sales by Country (2017-2022)

5.1.2 Americas Irbesartan Revenue by Country (2017-2022)

5.2 Americas Irbesartan Sales by Type

5.3 Americas Irbesartan Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Irbesartan Sales by Region

6.1.1 APAC Irbesartan Sales by Region (2017-2022)

6.1.2 APAC Irbesartan Revenue by Region (2017-2022)

6.2 APAC Irbesartan Sales by Type

6.3 APAC Irbesartan Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Irbesartan by Country

7.1.1 Europe Irbesartan Sales by Country (2017-2022)

7.1.2 Europe Irbesartan Revenue by Country (2017-2022)

7.2 Europe Irbesartan Sales by Type

7.3 Europe Irbesartan Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Irbesartan by Country

8.1.1 Middle East & Africa Irbesartan Sales by Country (2017-2022)

8.1.2 Middle East & Africa Irbesartan Revenue by Country (2017-2022)

8.2 Middle East & Africa Irbesartan Sales by Type

8.3 Middle East & Africa Irbesartan Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Irbesartan

10.3 Manufacturing Process Analysis of Irbesartan

10.4 Industry Chain Structure of Irbesartan

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Irbesartan Distributors

11.3 Irbesartan Customer

12 World Forecast Review for Irbesartan by Geographic Region

12.1 Global Irbesartan Market Size Forecast by Region

12.1.1 Global Irbesartan Forecast by Region (2023-2028)

12.1.2 Global Irbesartan Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Irbesartan Forecast by Type

12.7 Global Irbesartan Forecast by Application

13 Key Players Analysis

13.1 Teva

13.1.1 Teva Company Information

13.1.2 Teva Irbesartan Product Offered

13.1.3 Teva Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Main Business Overview

13.1.5 Teva Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Irbesartan Product Offered

13.2.3 Sanofi Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 BMS

13.3.1 BMS Company Information

13.3.2 BMS Irbesartan Product Offered

13.3.3 BMS Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BMS Main Business Overview

13.3.5 BMS Latest Developments

13.4 Sumitomo Dainippon Pharma

13.4.1 Sumitomo Dainippon Pharma Company Information

13.4.2 Sumitomo Dainippon Pharma Irbesartan Product Offered

13.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sumitomo Dainippon Pharma Main Business Overview

13.4.5 Sumitomo Dainippon Pharma Latest Developments

13.5 Novartis

13.5.1 Novartis Company Information

13.5.2 Novartis Irbesartan Product Offered

13.5.3 Novartis Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novartis Main Business Overview

13.5.5 Novartis Latest Developments

13.6 Shionogi

13.6.1 Shionogi Company Information

13.6.2 Shionogi Irbesartan Product Offered

13.6.3 Shionogi Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Shionogi Main Business Overview

13.6.5 Shionogi Latest Developments

13.7 Hanall

13.7.1 Hanall Company Information

13.7.2 Hanall Irbesartan Product Offered

13.7.3 Hanall Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hanall Main Business Overview

13.7.5 Hanall Latest Developments

13.8 Taj Pharmaceuticals

13.8.1 Taj Pharmaceuticals Company Information

13.8.2 Taj Pharmaceuticals Irbesartan Product Offered

13.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Taj Pharmaceuticals Main Business Overview

13.8.5 Taj Pharmaceuticals Latest Developments

13.9 Apotex

13.9.1 Apotex Company Information

13.9.2 Apotex Irbesartan Product Offered

13.9.3 Apotex Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Apotex Main Business Overview

13.9.5 Apotex Latest Developments

13.10 Jiangsu Hengrui Medicine

13.10.1 Jiangsu Hengrui Medicine Company Information

13.10.2 Jiangsu Hengrui Medicine Irbesartan Product Offered

13.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Jiangsu Hengrui Medicine Main Business Overview

13.10.5 Jiangsu Hengrui Medicine Latest Developments

13.11 Verdant Life Sciences

13.11.1 Verdant Life Sciences Company Information

13.11.2 Verdant Life Sciences Irbesartan Product Offered

13.11.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Verdant Life Sciences Main Business Overview

13.11.5 Verdant Life Sciences Latest Developments

13.12 Angita Pharma

13.12.1 Angita Pharma Company Information

13.12.2 Angita Pharma Irbesartan Product Offered

13.12.3 Angita Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Angita Pharma Main Business Overview

13.12.5 Angita Pharma Latest Developments

13.13 Auro Pharma

13.13.1 Auro Pharma Company Information

13.13.2 Auro Pharma Irbesartan Product Offered

13.13.3 Auro Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Auro Pharma Main Business Overview

13.13.5 Auro Pharma Latest Developments

13.14 Avanstra

13.14.1 Avanstra Company Information

13.14.2 Avanstra Irbesartan Product Offered

13.14.3 Avanstra Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Avanstra Main Business Overview

13.14.5 Avanstra Latest Developments

13.15 Zhuhai Rundu Pharma

13.15.1 Zhuhai Rundu Pharma Company Information

13.15.2 Zhuhai Rundu Pharma Irbesartan Product Offered

13.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Zhuhai Rundu Pharma Main Business Overview

13.15.5 Zhuhai Rundu Pharma Latest Developments

13.16 Xiansheng Pharmaceutical

13.16.1 Xiansheng Pharmaceutical Company Information

13.16.2 Xiansheng Pharmaceutical Irbesartan Product Offered

13.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Xiansheng Pharmaceutical Main Business Overview

13.16.5 Xiansheng Pharmaceutical Latest Developments

13.17 CTTQ

13.17.1 CTTQ Company Information

13.17.2 CTTQ Irbesartan Product Offered

13.17.3 CTTQ Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 CTTQ Main Business Overview

13.17.5 CTTQ Latest Developments

13.18 Tianjin Huairen Pharmaceutical

13.18.1 Tianjin Huairen Pharmaceutical Company Information

13.18.2 Tianjin Huairen Pharmaceutical Irbesartan Product Offered

13.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Tianjin Huairen Pharmaceutical Main Business Overview

13.18.5 Tianjin Huairen Pharmaceutical Latest Developments

13.19 Jiangsu Wangao Pharmaceutical

13.19.1 Jiangsu Wangao Pharmaceutical Company Information

13.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Product Offered

13.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Jiangsu Wangao Pharmaceutical Main Business Overview

13.19.5 Jiangsu Wangao Pharmaceutical Latest Developments

13.20 Zhejiang Huahai Pharmaceutical

13.20.1 Zhejiang Huahai Pharmaceutical Company Information

13.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Product Offered

13.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview

13.20.5 Zhejiang Huahai Pharmaceutical Latest Developments

13.21 Zhejiang Ainuo Pharmaceutical

13.21.1 Zhejiang Ainuo Pharmaceutical Company Information

13.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Product Offered

13.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Zhejiang Ainuo Pharmaceutical Main Business Overview

13.21.5 Zhejiang Ainuo Pharmaceutical Latest Developments

13.22 Yuanhe Pharmaceutical

13.22.1 Yuanhe Pharmaceutical Company Information

13.22.2 Yuanhe Pharmaceutical Irbesartan Product Offered

13.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Yuanhe Pharmaceutical Main Business Overview

13.22.5 Yuanhe Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Irbesartan Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Irbesartan Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Combination Drugs

Table 4. Major Players of Prescribed Drugs

Table 5. Global Irbesartan Sales by Type (2017-2022) & (KG)

Table 6. Global Irbesartan Sales Market Share by Type (2017-2022)

Table 7. Global Irbesartan Revenue by Type (2017-2022) & ($ million)

Table 8. Global Irbesartan Revenue Market Share by Type (2017-2022)

Table 9. Global Irbesartan Sale Price by Type (2017-2022) & (US$/G)

Table 10. Global Irbesartan Sales by Application (2017-2022) & (KG)

Table 11. Global Irbesartan Sales Market Share by Application (2017-2022)

Table 12. Global Irbesartan Revenue by Application (2017-2022)

Table 13. Global Irbesartan Revenue Market Share by Application (2017-2022)

Table 14. Global Irbesartan Sale Price by Application (2017-2022) & (US$/G)

Table 15. Global Irbesartan Sales by Company (2020-2022) & (KG)

Table 16. Global Irbesartan Sales Market Share by Company (2020-2022)

Table 17. Global Irbesartan Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Irbesartan Revenue Market Share by Company (2020-2022)

Table 19. Global Irbesartan Sale Price by Company (2020-2022) & (US$/G)

Table 20. Key Manufacturers Irbesartan Producing Area Distribution and Sales Area

Table 21. Players Irbesartan Products Offered

Table 22. Irbesartan Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Irbesartan Sales by Geographic Region (2017-2022) & (KG)

Table 26. Global Irbesartan Sales Market Share Geographic Region (2017-2022)

Table 27. Global Irbesartan Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Irbesartan Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Irbesartan Sales by Country/Region (2017-2022) & (KG)

Table 30. Global Irbesartan Sales Market Share by Country/Region (2017-2022)

Table 31. Global Irbesartan Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Irbesartan Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Irbesartan Sales by Country (2017-2022) & (KG)

Table 34. Americas Irbesartan Sales Market Share by Country (2017-2022)

Table 35. Americas Irbesartan Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Irbesartan Revenue Market Share by Country (2017-2022)

Table 37. Americas Irbesartan Sales by Type (2017-2022) & (KG)

Table 38. Americas Irbesartan Sales Market Share by Type (2017-2022)

Table 39. Americas Irbesartan Sales by Application (2017-2022) & (KG)

Table 40. Americas Irbesartan Sales Market Share by Application (2017-2022)

Table 41. APAC Irbesartan Sales by Region (2017-2022) & (KG)

Table 42. APAC Irbesartan Sales Market Share by Region (2017-2022)

Table 43. APAC Irbesartan Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Irbesartan Revenue Market Share by Region (2017-2022)

Table 45. APAC Irbesartan Sales by Type (2017-2022) & (KG)

Table 46. APAC Irbesartan Sales Market Share by Type (2017-2022)

Table 47. APAC Irbesartan Sales by Application (2017-2022) & (KG)

Table 48. APAC Irbesartan Sales Market Share by Application (2017-2022)

Table 49. Europe Irbesartan Sales by Country (2017-2022) & (KG)

Table 50. Europe Irbesartan Sales Market Share by Country (2017-2022)

Table 51. Europe Irbesartan Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Irbesartan Revenue Market Share by Country (2017-2022)

Table 53. Europe Irbesartan Sales by Type (2017-2022) & (KG)

Table 54. Europe Irbesartan Sales Market Share by Type (2017-2022)

Table 55. Europe Irbesartan Sales by Application (2017-2022) & (KG)

Table 56. Europe Irbesartan Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Irbesartan Sales by Country (2017-2022) & (KG)

Table 58. Middle East & Africa Irbesartan Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Irbesartan Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Irbesartan Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Irbesartan Sales by Type (2017-2022) & (KG)

Table 62. Middle East & Africa Irbesartan Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Irbesartan Sales by Application (2017-2022) & (KG)

Table 64. Middle East & Africa Irbesartan Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Irbesartan

Table 66. Key Market Challenges & Risks of Irbesartan

Table 67. Key Industry Trends of Irbesartan

Table 68. Irbesartan Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Irbesartan Distributors List

Table 71. Irbesartan Customer List

Table 72. Global Irbesartan Sales Forecast by Region (2023-2028) & (KG)

Table 73. Global Irbesartan Sales Market Forecast by Region

Table 74. Global Irbesartan Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Irbesartan Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Irbesartan Sales Forecast by Country (2023-2028) & (KG)

Table 77. Americas Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Irbesartan Sales Forecast by Region (2023-2028) & (KG)

Table 79. APAC Irbesartan Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Irbesartan Sales Forecast by Country (2023-2028) & (KG)

Table 81. Europe Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Irbesartan Sales Forecast by Country (2023-2028) & (KG)

Table 83. Middle East & Africa Irbesartan Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Irbesartan Sales Forecast by Type (2023-2028) & (KG)

Table 85. Global Irbesartan Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Irbesartan Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Irbesartan Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Irbesartan Sales Forecast by Application (2023-2028) & (KG)

Table 89. Global Irbesartan Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Irbesartan Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Irbesartan Revenue Market Share Forecast by Application (2023-2028)

Table 92. Teva Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 93. Teva Irbesartan Product Offered

Table 94. Teva Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 95. Teva Main Business

Table 96. Teva Latest Developments

Table 97. Sanofi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi Irbesartan Product Offered

Table 99. Sanofi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 100. Sanofi Main Business

Table 101. Sanofi Latest Developments

Table 102. BMS Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 103. BMS Irbesartan Product Offered

Table 104. BMS Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 105. BMS Main Business

Table 106. BMS Latest Developments

Table 107. Sumitomo Dainippon Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 108. Sumitomo Dainippon Pharma Irbesartan Product Offered

Table 109. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 110. Sumitomo Dainippon Pharma Main Business

Table 111. Sumitomo Dainippon Pharma Latest Developments

Table 112. Novartis Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 113. Novartis Irbesartan Product Offered

Table 114. Novartis Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 115. Novartis Main Business

Table 116. Novartis Latest Developments

Table 117. Shionogi Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 118. Shionogi Irbesartan Product Offered

Table 119. Shionogi Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 120. Shionogi Main Business

Table 121. Shionogi Latest Developments

Table 122. Hanall Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 123. Hanall Irbesartan Product Offered

Table 124. Hanall Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 125. Hanall Main Business

Table 126. Hanall Latest Developments

Table 127. Taj Pharmaceuticals Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 128. Taj Pharmaceuticals Irbesartan Product Offered

Table 129. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 130. Taj Pharmaceuticals Main Business

Table 131. Taj Pharmaceuticals Latest Developments

Table 132. Apotex Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 133. Apotex Irbesartan Product Offered

Table 134. Apotex Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 135. Apotex Main Business

Table 136. Apotex Latest Developments

Table 137. Jiangsu Hengrui Medicine Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 138. Jiangsu Hengrui Medicine Irbesartan Product Offered

Table 139. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 140. Jiangsu Hengrui Medicine Main Business

Table 141. Jiangsu Hengrui Medicine Latest Developments

Table 142. Verdant Life Sciences Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 143. Verdant Life Sciences Irbesartan Product Offered

Table 144. Verdant Life Sciences Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 145. Verdant Life Sciences Main Business

Table 146. Verdant Life Sciences Latest Developments

Table 147. Angita Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 148. Angita Pharma Irbesartan Product Offered

Table 149. Angita Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 150. Angita Pharma Main Business

Table 151. Angita Pharma Latest Developments

Table 152. Auro Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 153. Auro Pharma Irbesartan Product Offered

Table 154. Auro Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 155. Auro Pharma Main Business

Table 156. Auro Pharma Latest Developments

Table 157. Avanstra Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 158. Avanstra Irbesartan Product Offered

Table 159. Avanstra Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 160. Avanstra Main Business

Table 161. Avanstra Latest Developments

Table 162. Zhuhai Rundu Pharma Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 163. Zhuhai Rundu Pharma Irbesartan Product Offered

Table 164. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 165. Zhuhai Rundu Pharma Main Business

Table 166. Zhuhai Rundu Pharma Latest Developments

Table 167. Xiansheng Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 168. Xiansheng Pharmaceutical Irbesartan Product Offered

Table 169. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 170. Xiansheng Pharmaceutical Main Business

Table 171. Xiansheng Pharmaceutical Latest Developments

Table 172. CTTQ Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 173. CTTQ Irbesartan Product Offered

Table 174. CTTQ Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 175. CTTQ Main Business

Table 176. CTTQ Latest Developments

Table 177. Tianjin Huairen Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 178. Tianjin Huairen Pharmaceutical Irbesartan Product Offered

Table 179. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 180. Tianjin Huairen Pharmaceutical Main Business

Table 181. Tianjin Huairen Pharmaceutical Latest Developments

Table 182. Jiangsu Wangao Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 183. Jiangsu Wangao Pharmaceutical Irbesartan Product Offered

Table 184. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 185. Jiangsu Wangao Pharmaceutical Main Business

Table 186. Jiangsu Wangao Pharmaceutical Latest Developments

Table 187. Zhejiang Huahai Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 188. Zhejiang Huahai Pharmaceutical Irbesartan Product Offered

Table 189. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 190. Zhejiang Huahai Pharmaceutical Main Business

Table 191. Zhejiang Huahai Pharmaceutical Latest Developments

Table 192. Zhejiang Ainuo Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 193. Zhejiang Ainuo Pharmaceutical Irbesartan Product Offered

Table 194. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 195. Zhejiang Ainuo Pharmaceutical Main Business

Table 196. Zhejiang Ainuo Pharmaceutical Latest Developments

Table 197. Yuanhe Pharmaceutical Basic Information, Irbesartan Manufacturing Base, Sales Area and Its Competitors

Table 198. Yuanhe Pharmaceutical Irbesartan Product Offered

Table 199. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 200. Yuanhe Pharmaceutical Main Business

Table 201. Yuanhe Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Irbesartan

Figure 2. Irbesartan Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Irbesartan Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Irbesartan Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Irbesartan Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Combination Drugs

Figure 10. Product Picture of Prescribed Drugs

Figure 11. Global Irbesartan Sales Market Share by Type in 2021

Figure 12. Global Irbesartan Revenue Market Share by Type (2017-2022)

Figure 13. Irbesartan Consumed in Hyperlipidemia

Figure 14. Global Irbesartan Market: Hyperlipidemia (2017-2022) & (KG)

Figure 15. Irbesartan Consumed in High Blood Pressure

Figure 16. Global Irbesartan Market: High Blood Pressure (2017-2022) & (KG)

Figure 17. Irbesartan Consumed in Heart Failure

Figure 18. Global Irbesartan Market: Heart Failure (2017-2022) & (KG)

Figure 19. Irbesartan Consumed in Kidney Disease

Figure 20. Global Irbesartan Market: Kidney Disease (2017-2022) & (KG)

Figure 21. Irbesartan Consumed in Fibrous Fibrillation

Figure 22. Global Irbesartan Market: Fibrous Fibrillation (2017-2022) & (KG)

Figure 23. Irbesartan Consumed in Other

Figure 24. Global Irbesartan Market: Other (2017-2022) & (KG)

Figure 25. Global Irbesartan Sales Market Share by Application (2017-2022)

Figure 26. Global Irbesartan Revenue Market Share by Application in 2021

Figure 27. Irbesartan Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Irbesartan Revenue Market Share by Company in 2021

Figure 29. Global Irbesartan Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Irbesartan Revenue Market Share by Geographic Region in 2021

Figure 31. Global Irbesartan Sales Market Share by Region (2017-2022)

Figure 32. Global Irbesartan Revenue Market Share by Country/Region in 2021

Figure 33. Americas Irbesartan Sales 2017-2022 (KG)

Figure 34. Americas Irbesartan Revenue 2017-2022 ($ Millions)

Figure 35. APAC Irbesartan Sales 2017-2022 (KG)

Figure 36. APAC Irbesartan Revenue 2017-2022 ($ Millions)

Figure 37. Europe Irbesartan Sales 2017-2022 (KG)

Figure 38. Europe Irbesartan Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Irbesartan Sales 2017-2022 (KG)

Figure 40. Middle East & Africa Irbesartan Revenue 2017-2022 ($ Millions)

Figure 41. Americas Irbesartan Sales Market Share by Country in 2021

Figure 42. Americas Irbesartan Revenue Market Share by Country in 2021

Figure 43. United States Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Irbesartan Sales Market Share by Region in 2021

Figure 48. APAC Irbesartan Revenue Market Share by Regions in 2021

Figure 49. China Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Irbesartan Sales Market Share by Country in 2021

Figure 56. Europe Irbesartan Revenue Market Share by Country in 2021

Figure 57. Germany Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Irbesartan Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Irbesartan Revenue Market Share by Country in 2021

Figure 64. Egypt Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Irbesartan Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Irbesartan in 2021

Figure 70. Manufacturing Process Analysis of Irbesartan

Figure 71. Industry Chain Structure of Irbesartan

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390